In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

460 News Items found
In the Clinic
MSK clinical geneticist Kenneth Offit and genetic counselor Yelena Kemel pictured in a laboratory
Testing for BRCA: What Is the Best Way to Screen for Cancer Genes?

The BRCA Founder Outreach study was recently launched to look at how patients undergo genetic screenings for cancer.
Support
MSK offers a number of support services for women going through menopause during or after breast cancer treatment.
How to Manage Menopause Symptoms after Breast Cancer

Learn how to manage menopause symptoms if you have breast cancer
Larry Norton, MD, and Hedvig Hricak, MD, PhD
MSK Researchers Use Simulation-Based Analysis to Estimate Increase in Breast Cancer Survival Worldwide Through Scale-up of Treatment and Early Detection

Memorial Sloan Kettering Cancer Center researchers join with experts from international institutions to estimate the potential impact of scaling up the availability of treatment and imaging modalities on breast cancer survival globally, together with improvements in quality of care.
In the Lab
A micrograph image of breast cancer cells.
Research Reveals How Sleeping Cancer Cells Wake Up

MSK investigators are studying how dormant cancer cells can become reactivated after remaining hidden in the body for years.
In the Clinic
Man and woman in white lab coats looking at test tubes
Single-Cell Analysis Enables Researchers to Understand the Differences within Tumors

Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.
Roundup
Crowded hall with ASCO signage
Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs

Couldn't make it to the American Society of Clinical Oncology's annual meeting this year? Read this summary of some main takeaways.
Memorial Sloan Kettering Researcher Examines Disparity in Job Retention in Breast Cancer Patients

Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis. Job loss can have devastating financial consequences, including increased risk of bankruptcy and debt. Victoria Blinder, MD, medical oncologist at Memorial Sloan Kettering, conducted a longitudinal study of a racially and ethnically diverse sample of employed women undergoing treatment for stage I-III breast cancer in New York City. For more information on this study, published in <i>Health Affairs</i> on February 6, 2017, and to speak with the study author, contact [email protected].
Article
Close up of microscope viewer.
MSK Research Highlights, October 15, 2024

New MSK research identifies a gene mutation associated with resistance to breast cancer treatment; reports encouraging results for expanding use of a new prostate cancer radiotherapy; determines the best radiation level for avoiding complications treating spinal tumors; and finds that proton therapy is effective against previously treated head and neck cancers.
In the Clinic
A doctor speaks with a patient who has advanced prostate cancer about inherited mutations.
Study Suggests Men with Metastatic Prostate Cancer Should Be Tested for Inherited Mutations

Learn why a new finding suggests that men with advanced prostate cancer should be screened for gene mutations.
In the Lab
Pictured: Joan Massagué
Study Links Cancer’s Ability to Spread with Chemotherapy Resistance

A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.